Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice
/in Breast Cancer, Dendritic Cells, International PublicationsAntitumor vaccination of patients with glioblastoma multiforme: a pilot study to assess feasibility, safety, and clinical benefit
/in Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease VirusDendritic cell-based immunotherapy in thyroid malignancies
/in Dendritic Cells, International Publications, Thyroid CancerClinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination
/in Dendritic Cells, Glioblastoma, International PublicationsTherapeutic cancer vaccines: using unique antigens
/in Dendritic Cells, Hyperthermia, International PublicationsFusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses
/in Breast Cancer, Dendritic Cells, International PublicationsVaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma
/in Dendritic Cells, Glioblastoma, International PublicationsAutologous dendritic cell vaccines for non-small-cell lung cancer
/in Dendritic Cells, International Publications, NSCLCGeneration of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy
/in Dendritic Cells, International Publications, Multiple Myeloma
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer